Literature DB >> 17689043

Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines.

L Capussotti1, A Ferrero, L Viganò, R Polastri, M Tabone.   

Abstract

EASL/AASLD guidelines clearly define indications for liver surgery for HCC: patients with single HCC and completely preserved liver function without portal hypertension. These guidelines exclude from operation many patients that could benefit from radical resection and that are daily scheduled for hepatectomy in surgical centers. Patients with large tumors or with portal vein thrombosis cannot be transplanted or treated by interstitial treatments. In selected cases liver resection may obtain good long-term outcomes, significantly better than non-curative therapies. In cases of multinodular HCC, liver transplantation is the treatment of choice within Milan criteria; patients beyond these limits can benefit from liver resection, especially if only two nodules are diagnosed: even if they have a worse prognosis, survival results after liver surgery are better than those reported after TACE or conservative treatments. EASL/AASLD guidelines excluded from operating patients with portal hypertension but data about this topic are not conclusive and further studies are necessary. Selected patients with mild portal hypertension could probably be scheduled for liver resection and, considering the shortage of donors, listing for transplantation could be avoided. In conclusion, guidelines for HCC treatment should consider good results of liver resection for advanced HCC, and indications for hepatectomy should be expanded in order not to exclude from radical therapy patients that could benefit from it.

Entities:  

Mesh:

Year:  2007        PMID: 17689043     DOI: 10.1016/j.ejso.2007.06.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  21 in total

1.  The modernized treatment of hepatocellular cancer: time to think twice!

Authors:  Jan Lerut
Journal:  Updates Surg       Date:  2011-12

Review 2.  Therapeutic options for intermediate-advanced hepatocellular carcinoma.

Authors:  Zong-Ming Zhang; Jin-Xing Guo; Zi-Chao Zhang; Nan Jiang; Zhen-Ya Zhang; Li-Jie Pan
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

3.  Laparoscopic liver resection in the treatment of HCC with liver cirrhosis: would it provide superiority to conventional open hepatectomy?

Authors:  Yuichiro Otsuka; Hironori Kaneko
Journal:  Hepatobiliary Surg Nutr       Date:  2017-10       Impact factor: 7.293

4.  Presentation and outcomes of hepatocellular carcinoma patients at a western centre.

Authors:  Krit Kitisin; Vignesh Packiam; Jennifer Steel; Abhinav Humar; T Clark Gamblin; David A Geller; J Wallis Marsh; Allan Tsung
Journal:  HPB (Oxford)       Date:  2011-08-11       Impact factor: 3.647

5.  Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.

Authors:  Jun-Jie Xiong; Kiran Altaf; Muhammad A Javed; Wei Huang; Rajarshi Mukherjee; Gang Mai; Robert Sutton; Xu-Bao Liu; Wei-Ming Hu
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

6.  Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection.

Authors:  Chuan Li; Wen-Jiang Zhu; Tian-Fu Wen; Yan Dai; Lu-Nan Yan; Bo Li; Jia-Yin Yang; Wen-Tao Wang; Ming-Qing Xu
Journal:  J Gastrointest Surg       Date:  2014-06-06       Impact factor: 3.452

7.  Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.

Authors:  Han Zhang; Shou-Xin Yuan; Shu-Yang Dai; Jin-Min Zhang; Xing Huang; Chong-De Lu; Jun-Hua Lu; Fu-Quan Wu; Wan Yee Lau; Meng-Chao Wu; Tian Yang; Feng Shen
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

Review 8.  Laparoscopic liver resection for the patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Zenichi Morise
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-16

9.  Best radiological response to trans-arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes.

Authors:  Jon C Henry; Lavina Malhotra; Hooman Khabiri; Gregory Guy; Anthony Michaels; James Hanje; Marcela Azevedo; Mark Bloomston; Carl R Schmidt
Journal:  HPB (Oxford)       Date:  2012-08-28       Impact factor: 3.647

10.  Perspective of laparoscopic liver resection for hepatocellular carcinoma.

Authors:  Zenichi Morise
Journal:  World J Gastrointest Surg       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.